The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
January 23rd 2025
Approximately 33.2% of patients who received semaglutide 7.2 mg achieved 25% or more weight loss after 72 weeks.
How Systemic Therapy Differs From Liver-directed Therapy When Treating Patients With NETs
November 9th 2021Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discussed how systemic therapy differs from liver-directed therapy.
Watch
Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discussed how liver-directed therapy is approached in the treatment of liver metastases in patients with gastrointestinal neuroendocrine tumors.
Watch
How Specialty Pharmacies Can Support Palliative Care During Cancer Treatment
November 8th 2021Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how palliative care can support the cancer treatment process, and how specialty pharmacies can support this type of care.
Watch
Pharmacy Focus Podcast: New Series - Psychedelic Pharmacy
November 5th 2021In this first episode of the new series, Executive Director of the Chacruna Institute Bia Labate, PhD, and Kelan Thomas, PharmD, MS, associate professor of clinical sciences at the Touro University California College of Pharmacy, discussed the global psychedelic medicine market.
Listen
FDA Accepts BLA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
November 3rd 2021The FDA also granted Priority Review designation for the toripalimab BLA and set a Prescription Drug User Fee Act action date for April 2022; however, the FDA is not currently planning to hold an advisory committee meeting to discuss the application.
Read More
Psychedelic Drug in Early Stages of Development Could Have Potential for Postpartum Depression
October 28th 2021Nathan Bryson, PhD, chief scientific officer of Field Trip Health, said the company's new psychedelic compound, FT-104, could have potential uses in the treatment of postpartum depression.
Watch
Overview of Burkitt Lymphoma, the Patient Populations Most Impacted
October 25th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.
Watch
Current Treatments, Drug Pipeline, Initial Management in Oncologic Emergencies
October 21st 2021Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains the initial management process for oncologic emergencies, the treatments currently available, and treatments coming in the drug pipeline.
Watch
Blockchain Has Potential For the Future of Personal Health Records, Electronic Health Records
October 21st 2021While Bitcoin and Ethereum garner most of the attention in the cryptocurrency space, there are a number of opportunities present for implementing blockchain into global health technology, with perhaps one of the most intuitive being its potential as a platform for health records.
Read More
How the National Blood Shortage May Impact Patient Care, Outcomes
October 21st 2021Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses how a national blood shortage could affect patient care and outcomes.
Watch